New oral weight loss pill enters human testing
NCT ID NCT07243171
Summary
This study is testing a new oral medication called ecnoglutide to see if it's safe and helps with weight loss in Chinese adults who are overweight or have obesity. Participants will take either the real pill or a placebo (dummy pill) daily or weekly for up to 24 weeks. Researchers will monitor side effects and measure changes in body weight and other health markers.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for WEIGHT MANAGEMENT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
China-Japan Friendship Hospital
RECRUITINGBeijing, Beijing Municipality, 100029, China
Contact Phone: •••-•••-••••
Conditions
Explore the condition pages connected to this study.